Pembelian

Clovis Oncology - Possible bottoming formation

355
CLVS has been beat up for a loooong time.

On a 3 hr chart it appears that we are seeing a bottoming inver H&S formation. Company also is making positive news about Rubraca that just met the primary endpoint of significantly improving Progression-Free Survival vs. Chemotherapy.

Completely a momentum based trade with a tight stop loss.

PS Never ever take any of my posts as financial advice.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.